Susquehanna International Group
SIOX

Susquehanna International Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Susquehanna International Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,400
Closed -$19K – 14366
2021
Q4 		$19K Sell
14,400
-14,700
-51% -$26.1K ﹤0.01% 12839
2021
Q3 		$63K Sell
29,100
-28,200
-49% -$61.3K ﹤0.01% 12269
2021
Q2 		$156K Buy
57,300
+28,000
+96% +$69.6K ﹤0.01% 11826
2021
Q1 		$76K Buy
29,300
+4,700
+19% +$13.3K ﹤0.01% 11951
2020
Q4 		$68K Sell
24,600
-31,500
-56% -$91.7K ﹤0.01% 10663
2020
Q3 		$259K Buy
56,100
+45,900
+450% +$151K ﹤0.01% 8998
2020
Q2 		$29K Sell
10,200
-14,600
-59% -$46.8K ﹤0.01% 9871
2020
Q1 		$61K Sell
24,800
-800
-3% -$2.89K ﹤0.01% 9586
2019
Q4 		$131K Sell
25,600
-24,300
-49% -$135K ﹤0.01% 9017
2019
Q3 		$322K Sell
49,900
-286,200
-85% -$1.97M ﹤0.01% 8153
2019
Q2 		$2.09M Buy
336,100
+327,925
+4,011% +$2.5M ﹤0.01% 4080
2019
Q1 		$87K Buy
8,175
+275
+3% +$2.74K ﹤0.01% 8302
2018
Q4 		$63K Sell
7,900
-10,600
-57% -$153K ﹤0.01% 8406
2018
Q3 		$358K Buy
18,500
+4,475
+32% +$81.4K ﹤0.01% 7130
2018
Q2 		$254K Sell
14,025
-35,513
-72% -$524K ﹤0.01% 8165
2018
Q1 		$527K Sell
49,538
-115,475
-70% -$1.85M ﹤0.01% 6527
2017
Q4 		$6.96M Buy
165,013
+6,288
+4% +$282K ﹤0.01% 2167
2017
Q3 		$8.74M Buy
158,725
+26,762
+20% +$4.51M ﹤0.01% 1891
2017
Q2 		$24.5M Buy
131,963
+84,863
+180% +$14.9M 0.01% 1010
2017
Q1 		$5.63M Buy
47,100
+387
+0.8% +$40.6K ﹤0.01% 2238
2016
Q4 		$4.64M Sell
46,713
-7,725
-14% -$813K ﹤0.01% 2545
2016
Q3 		$6.1M Buy
54,438
+51,250
+1,608% +$6.15M ﹤0.01% 2020
2016
Q2 		$327K Buy
3,188
+1,150
+56% +$115K ﹤0.01% 6816
2016
Q1 		$187K Sell
2,038
-5,000
-71% -$533K ﹤0.01% 8022
2015
Q4 		$1.01M Sell
7,038
-7,950
-53% -$1.03M ﹤0.01% 5371
2015
Q3 		$1.55M Buy
14,988
+13,688
+1,053% +$1.61M ﹤0.01% 4802
2015
Q2 		$212K Buy
+1,300
New +$220K ﹤0.01% 9195

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Susquehanna International Group's SIOX Position: Q1 2023 in Review

Susquehanna International Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 95,387 shares — an estimated $41.5K sold.

Susquehanna International Group first reported a position in SIOX in Q3 2015 and held it in 21 quarters. The position peaked at $1.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Susquehanna International Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 95,387 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $41.5K.
  • Susquehanna International Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 21 quarters.
  • Susquehanna International Group's Sio Gene Therapies Inc. Common Stock position peaked at $1.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.